Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of KW-2246 for Breakthrough Cancer Pain
NCT00683995Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2008
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in breakthrough pain, sponsored by Kyowa Kirin. Primary endpoint: Safety and Tolerability. Started Mar 2008; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00683995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683995.